Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2020-01-30 | 2020-03-12 | 104896 |
| TEVA-ERLOTINIB | 25MG | TABLET | Resolved | 2024-06-07 | 2024-08-01 | 229957 |
| TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2024-06-07 | 2024-08-08 | 229960 |
| TEVA-ERLOTINIB | 150MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176830 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-08 | 170779 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2022-09-30 | 2022-12-02 | 170798 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-02-13 | 2020-03-12 | 106008 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-07-09 | 2021-02-05 | 119877 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-08-20 | 2020-09-24 | 122717 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-03-13 | 2018-12-07 | 42562 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179183 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180906 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-08 | 2023-06-27 | 194141 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195133 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-19 | 106928 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-12 | 106948 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-03-26 | 2020-06-18 | 109598 |
| TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110688 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-04-16 | 2020-06-18 | 112379 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-10-17 | 2024-11-21 | 240516 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |